LEIGH VAN DEVENDER: Open Payments
NPI 1376198192 · OXFORD, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,230 in 175 payments from 18 companies in 2025. Trend: 2023 $3,282 · 2024 $3,958 · 2025 $3,230
Food & beverage: $3,187Education: $43
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $691 |
| Amgen Inc. | 34 | $625 |
| Novartis Pharmaceuticals Corporation | 35 | $372 |
| Janssen Biotech, Inc. | 13 | $270 |
| UCB, Inc. | 14 | $250 |
| AstraZeneca Pharmaceuticals LP | 9 | $196 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $138 |
| Organon LLC | 5 | $116 |
| Lilly USA, LLC | 5 | $102 |
| ANI Pharmaceuticals, Inc. | 4 | $85 |
Products named: RINVOQ, COSENTYX, OTEZLA, TREMFYA, Bimzelx, SKYRIZI, SAPHNELO, TAVNEOS.
Industry payments across MS — which companies pay providers there.
